CANNASEN Psoriasis Gel

Organization name

Cannordic A/S

SRN

DK-MF-000003852

Manufacturer status

Active

1 warning recorded — scroll inside the panel to see all entries.

• CW999

  Do not use in case of hypersensitivity (allergy) to any of the ingredients.

Primary placement in Denmark; available across 2 countries total.

Trade name

CANNASEN Psoriasis Gel

UDI-DI code

05744000130378

Basic UDI-DI

574400013MDPSOG20MU

Reference / catalog number

10252203174

Issuing entity

GS1

Risk category

Class I

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

The Psoriasis Gel is formulated to support treatment and relieve symptoms of psoriasis. The Dead Sea salt in the gel is responsible for the desired effect of the product as it helps promote the shedding of dead skin cells and reduces redness caused by skin scales and dryness. When applied, the gel creates an osmotic effect and helps to retain moisture. This is achieved through the attraction and retention of water by the salt solution in the gel. The conductive cooling effect of ethanol/water mixture supports this. Additionally, the Psoriasis Gel includes skincare ingredients that improve skin hydration and prevent the formation of new scales.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• M04040102SALINE DRESSINGS IN COMBINATION WITH OTHER SUBSTANCES